These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 666466)

  • 1. Digoxin metabolism in patients.
    Peters U; Falk LC; Kalman SM
    Arch Intern Med; 1978 Jul; 138(7):1074-6. PubMed ID: 666466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dihydrogenated metabolites of digoxin: clinical importance and identification (author's transl)].
    Peters U; Kalman SM
    Z Kardiol; 1978 May; 67(5):342-5. PubMed ID: 654418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin inactivation by the gut flora in infancy and childhood.
    Linday L; Dobkin JF; Wang TC; Butler VP; Saha JR; Lindenbaum J
    Pediatrics; 1987 Apr; 79(4):544-8. PubMed ID: 3822671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of urinary digoxin and dihydrodigoxin by radioimmunoassay and by mass spectroscopy.
    Greenwood H; Snedden W; Hayward RP; Landon J
    Clin Chim Acta; 1975 Jul; 62(2):213-24. PubMed ID: 1170963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological availability of diagoxin in patients with or without gastric resection (Billroth II) (author's transl)].
    Ochs H; Bodem G; Kodrat G; Savic B; Baur MP
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2430-4. PubMed ID: 810339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite.
    Butler VP; Tse-Eng D; Lindenbraum J; Kalman SM; Preibisz JJ; Rund DG; Wissel PS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):123-31. PubMed ID: 7062278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of [20R]-dihydrodigoxin from digoxin in humans.
    Reuning RH; Shepard TA; Morrison BE; Bockbrader HN
    Drug Metab Dispos; 1985; 13(1):51-7. PubMed ID: 2858377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tritiated digoxin: studies in renal disease in human subjects.
    Doherty JE; Bissett JK; Kane JJ; de Soyza N; Murphy ML; Flanigan WJ; Dalrymple GV
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):89-95. PubMed ID: 1100542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary excretion studies with digoxin in man.
    Klotz U; Antonin KH
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):332-4. PubMed ID: 892949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of digoxin and its metabolites in hyperacidic patients and in patients during coronary care.
    Magnusson JO; Bergdahl B; Gustafsson S
    Arzneimittelforschung; 1984; 34(1):87-9. PubMed ID: 6538426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction of digoxin and quinidine].
    Haustein KO; Oltmanns G
    Z Gesamte Inn Med; 1980 Feb; 35(4):186-7. PubMed ID: 7405308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine.
    Allonen H; Iisalo E; Kangas L; Lammintausta R; Salonen M
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):420-3. PubMed ID: 700915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of age to the metabolism and protein binding of digoxin in sheep.
    Berman W; Musselman J
    J Pharmacol Exp Ther; 1979 Feb; 208(2):263-6. PubMed ID: 762659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two compartment open model for digoxin pharmacokinetics in patients receiving a wide range of digoxin doses.
    Rabkin SW; Grupp G
    Acta Cardiol; 1975; 30(5):343-51. PubMed ID: 1082700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic digoxin, hemispheric chemical dominance, and interstitial lung disease.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Oct; 113(10):1427-43. PubMed ID: 14534040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical evaluation of digoxin dosage in patients with heart failure].
    Jabłecka A
    Wiad Lek; 1994 Aug; 47(15-16):579-82. PubMed ID: 7716953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal clearance of digoxin in young infants.
    Gorodischer R; Jusko WJ; Yaffe SJ
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):363-74. PubMed ID: 847290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.